leisure time -WSS

leisure time

author：entertainment 2025-09-03 11:51:13 - browse：3215

Each COVID-19 vaccine vial from various companies is placed on individual rectangular backgrounds. Pfizer-BioNTech is positioned in the middle on a purple block adorned with two glitter star stickers, Moderna is on the top right on a red block, Janssen is on the bottom right on a blue block, and AstraZeneca is on the left on a red block. — Illustration: Christine Kao/STAT; Photos: Getty

It’s been four years since Covid-19 emerged, igniting a pandemic that killed millions of people and brought the world to its knees. A key factor in taming the pandemic was the creation of effective vaccines, which have saved millions of lives.

You’d think developing a successful vaccine would be an unmitigated win, from a financial perspective. And, indeed, for Pfizer and its partner BioNTech, as well as for Moderna — whose vaccines were the most widely used in the United States and much of the world — the revenues generated were absolutely staggering. But investors have shrugged at those sales as gains that will not be repeated.

Total sales of the Pfizer/BioNTech vaccine surpassed $80 billion, and more than 400 million doses of the shot and subsequent boosters have been administered in the U.S. alone. But the company’s stock price fell 32% over the past five years. Meanwhile, AstraZeneca, which told STAT it has not booked sales from its vaccine since last April and does not expect future sales, has seen its share price rise 64%. Merck, which saw its vaccine efforts fail twice, is up 56%.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： FDA approves first blood sugar monitor without finger pricks

hotspot

WSS

Sophia Smith scores twice for US in in 3

Indictment alleges Trump's ex

Timeline: How the deadly wildfires took over Maui day by day

Idaho college killings prosecutors challenge defense's grand jury claims

Be careful with at

PrEP can help anyone prevent HIV. Why do so few people take it?

leisure time

leisure time

hotspot

How to save PrEP access — and even expand it

Novartis develops a rapidly manufactured CAR

Continuity nursing helped my family in our darkest PICU moments

Weekend shootings leave at least 6 dead, 20 others wounded in Chicago

Moonlake's readout produced a cash windfall. Risks remain

Montana youths win climate lawsuit against state for promoting fossil fuels

DIEP, the 'gold standard' of breast reconstruction, is under threat

Illinois Supreme Court finds assault weapons ban constitutional

Dobbs anniversary: the lost opportunity of abortion as health care

Novartis develops a rapidly manufactured CAR

knowledge

Be careful with at

Senators push IRS to launch nonprofit hospital probe

FAMU bans football players from facility after release of rap video shot in team's locker room

'The Earth is screaming at us': Gov. Inslee calls for climate action amid record heat

Yogurt drink instead of a colonoscopy? CRISPR bacteria are tested

Illinois Supreme Court finds assault weapons ban constitutional

hotspot

hotspot

focus

focus